Dongha Kim

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

Nature communications

International journal of molecular sciences

Signal transduction and targeted therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Dongha Kim, Hye Jin Nam
PARP Inhibitors: Clinical Limitations and Recent Attempts to Overcome Them. International journal of molecular sciences 23 (15) (2022)
Kyung Soo Hong, June Hong Ahn, Jong Geol Jang, Jong Ho Lee, Hong Nam Kim, Dongha Kim, Wonhwa Lee
GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro. Signal transduction and targeted therapy 5 (1) (2020)
Young Suk Yu, Hijai R Shin, Dongha Kim, Seon Ah Baek, Seon Ah Choi, Hyejin Ahn, Amen Shamim, Jeonghwan Kim, Ik Soo Kim, Kyeong Kyu Kim, Kyoung-Jae Won, Sung Hee Baek
Pontin arginine methylation by CARM1 is crucial for epigenetic regulation of autophagy. Nature communications 11 (1) (2020)